UnitedHealth Group Inc (NYSE:UNH) was downgraded by equities researchers at Citigroup Inc. from a “buy” rating to a “neutral” rating in a research report issued on Wednesday, TheFlyOnTheWall.com reports. They currently have a $79.00 price objective on the stock. UnitedHealth Group Inc. (NYSE:UNH) shares after opening at $75.44 moved to $76.65 on last trade day and at the end of the day closed at $75.78. Company price to sales ratio in past twelve months was calculated as 0.61 and price to cash ratio as 10.30. UnitedHealth Group Inc. (NYSE:UNH) showed a negative weekly performance of -5.26%.
Aetna Inc (NYSE:AET), Tenet’s Baptist Health System and HealthTexas Medical Group announced an accountable care collaboration and the introduction of the Aetna Whole Health product in the San Antonio area. Aetna Whole Health is a collection of benefits plans that will give members access to highly coordinated care from physicians and facilities in the Baptist Health System and the HealthTexas Medical Group. Aetna Inc (NYSE:AET) shares fell -3.01% in last trading session and ended the day on $67.77. AET return on equity ratio is recorded as 14.80% and its return on assets is 4.00%. Aetna Inc (NYSE:AET) yearly performance is 26.65%.
Repligen Corporation (NASDAQ:RGEN) replaced Hi-Tech Pharmacal Co., Inc. (HITK) in the S&P SmallCap 600 after the close of trading on Thursday, April 17. S&P SmallCap 600 constituent Akorn Inc. (AKRX) is acquiring Hi-Tech Pharmacal Co. in a deal expected to be completed soon. Repligen Corporation (NASDAQ:RGEN) shares moved up 2.86% in last trading session and was closed at $15.84 while trading in range of $15.22 – $16.22 – Repligen Corporation (NASDAQ:RGEN) year to date (YTD) performance is 16.13%.
Zalicus Inc. (NASDAQ:ZLCS) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Epirus Biopharmaceuticals, Inc., a privately held biopharmaceutical company (“Epirus”) and BRunning, Inc., a wholly owned subsidiary of Zalicus Inc (NASDAQ:ZLCS) , pursuant to which the Merger Subsidiary will be merged with and into Epirus (the “Merger”) at the effective time of the Merger, with Epirus continuing after the Merger as the surviving corporation and a wholly-owned subsidiary of Zalicus. Zalicus Inc (NASDAQ:ZLCS) on last trading day company shares ended up $1.21. Zalicus Inc (NASDAQ:ZLCS) distance from 50-day simple moving average (SMA50) is -11.16%. Analysts mean target price for the company is $1.20.